OCPN

Olympus Corporation (OCPNF)

Market Closed
5 Dec, 20:00
OTC PINK OTC PINK
$
11. 58
0
0%
$
2.84T Market Cap
51.17 P/E Ratio
72% Div Yield
0 Volume
0 Eps
$ 11.58
Previous Close
Day Range
11.58 11.58
Year Range
10.89 15.75
Want to track OCPNF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days

Summary

OCPNF closed Friday higher at $11.58, an increase of 0% from Thursday's close, completing a monthly decrease of -13.26% or $1.77. Over the past 12 months, OCPNF stock lost -25.29%.
OCPNF pays dividends to its shareholders, with the most recent payment made on Jun 05, 2025. The next estimated payment will be in 6 months ago on Jun 05, 2025 for a total of $0.1334.
The last earnings report, released on Nov 07, 2025, missed the consensus estimates by -16.09%. On average, the company has fell short of earnings expectations by -5.36%, based on the last three reports. The next scheduled earnings report is due on Feb 13, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

OCPNF Chart

Similar

SK Hynix Inc.
$ 41.71
0%
Olympus Corporation - ADR
$ 13.12
+0.46%
Omron Corporation
$ 29.5
0%
Tencent Holdings Ltd UNS ADR
$ 78.19
+0.09%
Tencent Holdings Ltd.
$ 78.35
+0.06%
Olympus Corporation (OLYMY) Q1 2025 Earnings Call Transcript

Olympus Corporation (OLYMY) Q1 2025 Earnings Call Transcript

Olympus Corporation (OTCPK:OLYMY) Q1 2025 Earnings Conference Call August 7, 2024 2:00 AM ET Company Participants Stefan Kaufmann - Executive President, CEO & Director Tatsuya Izumi - Executive Officer & CFO Gabriela Kaynor - Executive Officer, Chief Strategy Officer Conference Call Participants Stefan Kaufmann Hello, everyone. I'm Stefan Kaufmann, CEO, and welcome to today's earnings call.

Seekingalpha | 1 year ago

Olympus Corporation (OCPNF) FAQ

What is the stock price today?

The current price is $11.58.

On which exchange is it traded?

Olympus Corporation is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is OCPNF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 72%.

What is its market cap?

As of today, the market cap is 2.84T.

What is the earnings per share?

The EPS is 18.96.

When is the next earnings date?

The next earnings report will release on Feb 13, 2026.

Has Olympus Corporation ever had a stock split?

No, there has never been a stock split.

Olympus Corporation Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Stefan Kaufmann CEO
OTC PINK Exchange
JP3201200007 ISIN
Japan Country
28,838 Employees
31 Mar 2026 Last Dividend
27 Mar 2019 Last Split
- IPO Date

Overview

Olympus Corporation, originally known as Olympus Optical Co., Ltd., is a global leader in the manufacturing and sale of precision machinery and instruments. The company has a rich history that dates back to its inception in 1919 and has its headquarters situated in Tokyo, Japan. Over the years, Olympus Corporation has undergone significant transformations, including a name change in October 2003, to better reflect its diversified product range and global presence. Olympus operates through four main business segments: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others. Each of these segments is geared towards providing innovative solutions in their respective fields, contributing to Olympus's reputation as a pioneer in medical and scientific equipment.

Products and Services

  • Endoscopic Solutions Business

    This segment delivers a comprehensive array of gastrointestinal and surgical endoscopy systems alongside surgical microscopes. Olympus also offers endoscope reprocessors and maintenance services, ensuring the durability and reliability of its endoscopic products. The focus here is on enhancing the efficiency of medical procedures and improving patient outcomes through state-of-the-art imaging and minimally invasive techniques.

  • Therapeutic Solutions Business

    Olympus's offering in this domain includes a variety of products for urology, gynecology, respiratory care, as well as ear, nose, and throat (ENT) treatments. The segment is particularly noted for its GI endo-therapy devices, energy devices, and surgical single-use devices, which are designed to facilitate complex therapeutic procedures with precision and care.

  • Scientific Solutions Business

    This segment caters to the needs of the scientific community, providing biological and industrial microscopes, industrial videoscopes, and non-destructive testing equipment. Additionally, Olympus supplies X-ray fluorescence (XRF) analyzers, instruments key in material analysis across various industries. The focus here is on delivering precision, enhancing research capabilities, and contributing to the advancement of science and industry.

  • Others

    Under this segment, Olympus develops and supplies biomedical materials such as synthetic bone fillers and orthopedic equipment. These products are a testament to Olympus’s commitment to extending its technological expertise beyond traditional boundaries and meeting the diverse needs of its global clientele.

Contact Information

Address: Shinjuku Monolith
Phone: 81 3 3340 2111